Provided by Tiger Trade Technology Pte. Ltd.

Jazz Pharmaceuticals PLC

243.71
-6.9700-2.78%
Post-market: 243.710.00000.00%16:15 EDT
Volume:1.07M
Turnover:262.98M
Market Cap:15.82B
PE:16.66
High:252.50
Open:250.13
Low:243.02
Close:250.68
52wk High:266.38
52wk Low:123.88
Shares:64.91M
Float Shares:62.69M
Volume Ratio:0.48
T/O Rate:1.71%
Dividend:- -
Dividend Rate:- -
EPS(TTM):14.63
EPS(LYR):-5.8403
ROE:22.11%
ROA:6.86%
PB:3.29
PE(LYR):-41.73

Loading ...

Jazz Pharmaceuticals Is Maintained at Overweight by Piper Sandler

Dow Jones
·
May 22

Bernstein Initiates Coverage on Jazz Pharmaceuticals With Market Perform Rating

MT Newswires Live
·
May 22

U.S. RESEARCH ROUNDUP-Jazz Pharmaceuticals, Target, Workday

Reuters
·
May 22

Jazz Pharmaceuticals Plc : Piper Sandler Raises Target Price to $301 From $232

THOMSON REUTERS
·
May 22

Bernstein starts Jazz at Market Perform, says clock ticking on blockbuster drugs

TIPRANKS
·
May 22

J.P. Morgan Reaffirms Their Buy Rating on Jazz Pharmaceuticals (JAZZ)

TIPRANKS
·
May 20

U.S. RESEARCH ROUNDUP-CAVA Group, Eagle Materials, Vertiv

Reuters
·
May 20

Jazz Pharmaceuticals Plc : JP Morgan Resumes Coverage With Overweight Rating; Price Target $265

THOMSON REUTERS
·
May 20

Jazz Pharmaceuticals Raised to Buy From Neutral by UBS

Dow Jones
·
May 19

UBS Revises Jazz Pharmaceuticals Outlook, Citing Strong Core Business and Promising Oncology Drug

Deep News
·
May 19

Lifeward names Keith D. Rose chief medical officer

Reuters
·
May 19

Jazz Pharmaceuticals Plc : UBS Raises to Buy From Neutral

THOMSON REUTERS
·
May 19

Jazz Pharmaceuticals upgraded to Buy from Neutral at UBS

TIPRANKS
·
May 19

Jazz Pharma joins RBC Global Healthcare Conference fireside chat

Reuters
·
May 13

Werewolf Therapeutics Q1 net loss narrows to $13.5 million; R&D expenses drop to $8.2 million

Reuters
·
May 08

ALX Oncology says evorpacept-zanidatamab trial shows durable responses in HER2+ breast cancer

Reuters
·
May 07

Jazz Pharmaceuticals price target raised to $234 from $225 at Barclays

TIPRANKS
·
May 07

Jazz Pharmaceuticals Plc : Jefferies Raises Target Price to $245 From $232

THOMSON REUTERS
·
May 07

Jazz Pharmaceuticals (JAZZ) Q1 EPS Rebound Tests Bearish Margin Narratives

Simply Wall St.
·
May 07

Jazz Pharmaceuticals Is Maintained at Overweight by Barclays

Dow Jones
·
May 06